Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine metformin

Details for Australian Patent Application No. 2009238271 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Souhami, Elisabeth; Silvestre, Louise; Wei, Xiaodan

Agent Watermark

Pub. Number AU-A-2009238271

Filing date 13 November 2009

Wipo publication date 2 June 2011

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

Event Publications

3 December 2009 Complete Application Filed

2 June 2011 Application Open to Public Inspection

  Published as AU-A-2009238271

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009238272-Method of treatment of diabetes type 2 comprising add-on therapy to metformin

2009238270-Compounds for treating muscular dystrophy